A pharmacokinetic and pharmacodynamic analysis of continuously infused piperacillin/tazobactam in critically ill trauma patients

被引：0
|
作者：
Silinskic, Kevin M. [1 ]
Domonoske, Brad [2 ]
Cocanour, Christine S. [3 ]
机构：
[1] Rochester Gen Hosp, Dept Pharm, Rochester, NY 14621 USA
[2] Mem Hermann Hosp, Dept Pharm, Houston, TX USA
[3] UC Davis Hlth Syst, Dept Surg, Sacramento, CA USA
来源：
CRITICAL CARE MEDICINE | 2007年 / 35卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
423
引用
收藏
页码：A115 / A115
页数：1
相关论文
共 50 条
  • [1] A pilot study on pharmacokinetic/pharmacodynamic target attainment in critically ill patients receiving piperacillin/tazobactam
    Martinkova, Jirina
    Malbrain, Manu L. N. G.
    Havel, Eduard
    Safranek, Petr
    Bezouska, Jan
    Kaska, Milan
    [J]. ANAESTHESIOLOGY INTENSIVE THERAPY, 2016, 48 (01) : 23 - 28
  • [2] An Integral Pharmacokinetic Analysis of Piperacillin and Tazobactam in Plasma and Urine in Critically Ill Patients
    Wallenburg, Eveline
    ter Heine, Rob
    Schouten, Jeroen A.
    Raaijmakers, Jelmer
    ten Oever, Jaap
    Kolwijck, Eva
    Burger, David M.
    Pickkers, Peter
    Frenzel, Tim
    Bruggemann, Roger J. M.
    [J]. CLINICAL PHARMACOKINETICS, 2022, 61 (06) : 907 - 918
  • [3] An Integral Pharmacokinetic Analysis of Piperacillin and Tazobactam in Plasma and Urine in Critically Ill Patients
    Eveline Wallenburg
    Rob ter Heine
    Jeroen A. Schouten
    Jelmer Raaijmakers
    Jaap ten Oever
    Eva Kolwijck
    David M. Burger
    Peter Pickkers
    Tim Frenzel
    Roger J. M. Brüggemann
    [J]. Clinical Pharmacokinetics, 2022, 61 : 907 - 918
  • [4] Correction to: An Integral Pharmacokinetic Analysis of Piperacillin and Tazobactam in Plasma and Urine in Critically Ill Patients
    Eveline Wallenburg
    Rob ter Heine
    Jeroen A. Schouten
    Jelmer Raaijmakers
    Jaap ten Oever
    Eva Kolwijck
    David M. Burger
    Peter Pickkers
    Tim Frenzel
    Roger J. M. Brüggemann
    [J]. Clinical Pharmacokinetics, 2022, 61 : 1325 - 1329
  • [5] Pharmacokinetic Analysis of Piperacillin Administered with Tazobactam in Critically Ill, Morbidly Obese Surgical Patients
    Sturm, Ashley W.
    Allen, Nichole
    Rafferty, Kelly D.
    Fish, Douglas N.
    Toschlog, Eric
    Newell, Mark
    Waibel, Brett
    [J]. PHARMACOTHERAPY, 2014, 34 (01): : 28 - 35
  • [6] Pharmacokinetic dose-approximation significantly increases pharmacokinetic target attainment during the first 24 h of treatment with continuously infused Piperacillin/Tazobactam in critically ill patients
    Richter, D. C.
    Frey, O.
    Roehr, A.
    Roberts, J. A.
    Koeberer, A.
    Fuchs, Th
    Brenner, T.
    Lichtenstein, C.
    Weigand, M. A.
    Brinkmann, A.
    [J]. INFECTION, 2019, 47 : S47 - S48
  • [7] Population pharmacokinetics of piperacillin and tazobactam in critically ill patients undergoing continuous renal replacement therapy: application to pharmacokinetic/pharmacodynamic analysis
    Asin-Prieto, Eduardo
    Rodriguez-Gascon, Alicia
    Troconiz, Inaki F.
    Soraluce, Amaia
    Maynar, Javier
    Angel Sanchez-Izquierdo, Jose
    Isla, Arantxazu
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (01) : 180 - 189
  • [8] Comparison of Piperacillin and Tazobactam Pharmacokinetics in Critically Ill Patients with Trauma or with Burn
    Selig, Daniel J.
    Akers, Kevin S.
    Chung, Kevin K.
    Kress, Adrian T.
    Livezey, Jeffrey R.
    Por, Elaine D.
    Pruskowski, Kaitlin A.
    DeLuca, Jesse P.
    [J]. ANTIBIOTICS-BASEL, 2022, 11 (05):
  • [9] Pharmacokinetic analysis of piperacillin administered with tazobactam in critically Ill, morbidly obese surgical patients.
    Sturm, Ashley W.
    Allen, Nichole
    Rafferty, Kelly D.
    Fish, Douglas N.
    Toschlog, Eric
    Newell, Mark
    Waibel, Brett
    [J]. PHARMACOTHERAPY, 2013, 33 (10): : E232 - E233
  • [10] Pharmacodynamic profiling of continuously infused piperacillin/tazobactam against Pseudomonas aeruginosa using Monte Carlo analysis
    Kuti, JL
    Nightingale, CH
    Quintiliani, R
    Nicolau, DP
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2002, 44 (01) : 51 - 57
12345